(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -1.58% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.83%.
Pfizer's revenue in 2025 is $62,785,000,000.On average, 27 Wall Street analysts forecast PFE's revenue for 2025 to be $357,204,576,954,400, with the lowest PFE revenue forecast at $340,744,453,591,360, and the highest PFE revenue forecast at $378,838,694,189,760. On average, 27 Wall Street analysts forecast PFE's revenue for 2026 to be $351,115,184,166,208, with the lowest PFE revenue forecast at $330,783,093,960,256, and the highest PFE revenue forecast at $374,858,698,903,360.
In 2027, PFE is forecast to generate $339,209,312,552,320 in revenue, with the lowest revenue forecast at $315,130,341,069,600 and the highest revenue forecast at $374,182,099,704,672.